Creatine and Peptide Therapy: How the Most-Studied Sports Supplement Interacts with Repair and GH-Axis Protocols

Creatine use raises questions about interpreting creatinine measurements, and this article examines supplement research and peptide care assessment.

By UAE Peptide Clinic Research Desk

Ask a room of patients on a peptide protocol what else they take and creatine monohydrate is usually the first answer. It is inexpensive, well tolerated, and supported by several hundred human trials, which makes it one of the few sports supplements with a genuinely robust evidence base. Yet it is rarely raised at prescription, and almost never in relation to how it might sit alongside a repair or GH-axis protocol. This article sets out where the two overlap, what the research actually shows, and one practical point about blood panels that catches many patients out.

What creatine does, in brief

Creatine is a naturally occurring compound stored mainly in skeletal muscle as phosphocreatine. Its primary role is to regenerate ATP during short, high-intensity effort, which is why the strongest evidence for supplementation sits in strength, power and repeated-sprint performance. Supplementation raises muscle creatine stores by roughly 20 to 40 percent in most people, and a consistent secondary effect is increased intracellular water retention within muscle, which accounts for the early rise in body weight that new users notice.

Beyond performance, research over the past decade has explored creatine in cognition, bone density, glucose handling and age-related muscle loss. Some of these findings are promising; most remain preliminary. It is worth holding that distinction, because the popular literature tends to blur it.

Where creatine and peptide protocols overlap

There are no published trials that combine creatine with BPC-157, TB-500 or growth hormone secretagogues directly, so anything said about their interaction is mechanistic inference rather than clinical evidence. With that caveat, three areas of overlap are worth understanding.

• Repair protocols and training load: studies link creatine with higher training volumes, and higher volume increases the mechanical load placed on tendons and connective tissue. For someone using a repair peptide to manage an existing injury, more training capacity is not automatically helpful and pacing still needs to come from the clinician, not the supplement.
• GH-axis protocols and lean mass: secretagogues such as ipamorelin or CJC-1295 are studied for their effects on body composition via IGF-1 signalling. Creatine acts through an entirely different pathway, cellular energy availability, so there is no known receptor-level conflict. The two are pharmacologically independent as far as current data shows.
• Hydration in the Gulf climate: creatine draws water into muscle tissue. In the UAE, where fluid loss through sweat is already high for much of the year, this raises daily hydration requirements. Patients on any subcutaneous protocol who are also taking creatine should treat water intake as a deliberate part of the plan, not an afterthought.

Creatine and peptides act through separate pathways. The practical interaction is not pharmacological but behavioural: training load, hydration, and how blood results are read.

The creatinine problem on your blood panel

This is the single most important clinical point for anyone combining the two. Creatine is metabolised to creatinine, the marker most laboratories use to estimate kidney function via eGFR. Regular creatine supplementation can raise serum creatinine modestly without any change in true renal function, because the extra creatinine reflects the supplement rather than the kidney. A clinician who does not know a patient is taking creatine may read a borderline creatinine as early renal impairment, and since GH-axis peptides are usually screened against renal function before prescription, that misreading can lead to unnecessary delays or investigations.

The solution is simple: declare creatine use on your intake form, and if a creatinine result comes back elevated, ask whether cystatin C, an alternative kidney marker unaffected by creatine, is available. Many UAE laboratories now offer it. Some clinicians also ask patients to pause creatine for a week before a baseline panel, which is a reasonable approach when the aim is a clean reference reading.

A note on dosing and forms

In studies, creatine monohydrate at three to five grams daily is the form and dose most often used, and trials comparing loading phases, buffered forms and liquid preparations have not shown meaningful added benefit. Any supplement use alongside a protocol is worth agreeing with the prescribing physician. For patients whose peptide protocol is focused on body composition, the temporary water-driven weight gain from creatine is worth anticipating so it is not mistaken for fat gain or misread at review.

If you want to understand whether any of this is relevant to you, an independent DHA-licensed physician can review your case. Take the two-minute quiz at /find-my-stack or book a physician consultation at /book (AED 300 deposit, credited to your first order).